Mukka Proteins: No deviation in warrant fund utilization

Mukka Proteins Limited has filed its Statement of Deviation and Variation for the quarter ended September 30, 2026. The company confirmed that there has been no deviation or variation in the utilization of funds raised through the preferential issue of warrants. The total amount raised was ₹47,00,00,000 (₹47 Crore). Funds were allocated for working capital, business expansion, and general corporate purposes. The statement was reviewed by the Audit Committee.